PHASE-II TRIAL OF M-AMSA THERAPY IN REFRACTORY HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA - CANCER AND LEUKEMIA GROUP-B STUDY 7972

被引：0
|
作者：
RYBAK, ME
ANDERSON, JR
POULIN, RF
AMREIN, PC
CANELLOS, GP
GOTTLIEB, AJ
机构：
[1] HARVARD UNIV, SCH PUBL HLTH, BOSTON, MA 02115 USA
[2] SUNY UPSTATE MED CTR, SYRACUSE, NY 13210 USA
[3] MASSACHUSETTS GEN HOSP, BOSTON, MA 02114 USA
[4] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, BOSTON, MA 02115 USA
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1233 / 1234
页数：2
相关论文
共 50 条
  • [31] CHEMOTHERAPY AND COMBINED MODALITY THERAPY FOR HODGKINS-DISEASE - A PROGRESS REPORT ON CANCER AND LEUKEMIA GROUP-B STUDIES
    BLOOMFIELD, CD
    PAJAK, TF
    GLICKSMAN, AS
    GOTTLIEB, AJ
    COLEMAN, M
    NISSEN, NI
    RAFLA, S
    STUTZMAN, L
    VINCIGUERRA, V
    GLIDEWELL, OJ
    HOLLAND, JF
    CANCER TREATMENT REPORTS, 1982, 66 (04): : 835 - 846
  • [32] PHASE-II STUDY OF AMSA IN PATIENTS WITH METASTATIC BREAST-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY
    AMREIN, PC
    COLEMAN, M
    RICHARDS, F
    POULIN, RF
    BERNHARDT, B
    GINSBERG, SJ
    GREEN, MR
    MORRISON, A
    CORTES, E
    KIANG, D
    WEINBERG, V
    WOOD, WC
    CANCER TREATMENT REPORTS, 1982, 66 (05): : 1211 - 1213
  • [33] PHASE-II TRIAL OF M-AMSA IN GALLBLADDER AND CHOLANGIOCARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    BUKOWSKI, RM
    LEICHMAN, LP
    RIVKIN, SE
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (06): : 721 - 723
  • [34] PHASE-II STUDY OF AMSACRINE (M-AMSA) IN THE TREATMENT OF PATIENTS WITH NON-HODGKIN LYMPHOMA
    ABATE, G
    VILLARI, P
    COMELLA, P
    CASTELLO, G
    DAPRILE, M
    BRUNI, G
    PERGOLA, M
    ZARILLI, D
    HAEMATOLOGICA, 1984, 69 (04) : 501 - 501
  • [35] COMBINED MODALITY TREATMENT OF ADVANCED HODGKINS-DISEASE - RANDOMIZED STUDY OF CANCER AND LEUKEMIA GROUP-B (CALGB)
    RAFLA, S
    COLEMAN, M
    PAJAK, T
    VINCIGUERRA, VP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 321 - 321
  • [36] MER IMMUNOTHERAPY AND COMBINATION CHEMOTHERAPY FOR ADVANCED, RECURRENT HODGKINS-DISEASE - CANCER AND LEUKEMIA GROUP-B STUDY
    VINCIGUERRA, V
    COLEMAN, M
    PAJAK, TF
    RAFLA, S
    STUTZMAN, L
    GOMEZ, G
    WEIL, M
    BRUNNER, K
    CUTTNER, J
    NISSEN, N
    LEVENTHAL, B
    GOTTLIEB, A
    CANCER CLINICAL TRIALS, 1981, 4 (02) : 99 - 105
  • [37] IDEC-C2B8 - FINAL REPORT ON A PHASE-II TRIAL IN RELAPSED NON-HODGKINS-LYMPHOMA
    MALONEY, DG
    BODKIN, D
    GRILLOLOPEZ, AJ
    WHITE, C
    FOON, K
    SCHILDER, R
    NEIDHART, J
    JANAKIRAMAN, N
    WALDICHUK, C
    VARNS, C
    ROYSTON, I
    LEVY, R
    BLOOD, 1994, 84 (10) : A169 - A169
  • [38] PHASE-II EVALUATION OF MAYTANSINE IN REFRACTORY NON-HODGKINS LYMPHOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    RATANATHARATHORN, V
    GADELMAWLA, N
    WILSON, HE
    BONNET, JD
    RIVKIN, SE
    MASS, R
    CANCER TREATMENT REPORTS, 1982, 66 (07): : 1587 - 1588
  • [39] REFRACTORY BREAST-CANCER - PHASE-II STUDY OF M-AMSA AND MITOMYCIN-C (MMC)
    VANOOSTEROM, AT
    SMITH, IE
    MUGGIA, FM
    ENGELSMAN, E
    POWLES, TJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 409 - 409
  • [40] DEXAMETHASONE IFOSFAMIDE CISPLATIN ETOPOSIDE (DICE) AS THERAPY FOR PATIENTS WITH ADVANCED REFRACTORY NON-HODGKINS-LYMPHOMA - PRELIMINARY-REPORT OF A PHASE-II STUDY
    GOSS, PE
    SHEPHERD, FA
    SCOTT, JG
    WARNER, E
    BAKER, MA
    SUTTON, D
    FARQUHARSON, HA
    BUICK, S
    SUTCLIFFE, S
    ANNALS OF ONCOLOGY, 1991, 2 : 43 - 46
12345